Type 1 Diabetes Trial, Recruiting NCT06984133 Sponsor: Dasman Diabetes Institute Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06984133
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adolescents of Arab background
  • Males and females between 11 and 14 years of age
  • People who have been diagnosed with type 1 diabetes for at least 6 months
  • People who are currently wearing a continuous glucose monitor (a small device that tracks blood sugar levels)
  • People whose parents or guardians are able to participate for the full length of the study
  • People whose parents or guardians are willing to give their permission, and who themselves agree to take part

Who may not be able to join:

  • People who have a learning disability or any known mental health or psychological condition
  • People who have attended a diabetes education program or a carbohydrate counting course in the six months before the study begins

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ebaa Al Ozairi, MD, Dasman Diabetes Institute

Phone: +965 22242999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dasman Diabetes Institute
Registry
ClinicalTrials.gov
Start date
18 May 2025
Est. completion
18 May 2028

Where this trial is recruiting

Kuwait

Primary endpoints

Change in HbA1c Levels; Change in %Time In Range (%TIR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov